Chris Dunne
Vice President, Finance

Mr. Dunne joined Novavax in 2010 and is responsible for managing all of Novavax’ financial reporting.  Prior to joining Novavax, he was Senior Director, Finance at Ore Pharmaceuticals (previously known as Gene Logic), a publicly traded biotechnology company, from 1996 until joining Novavax in 2010. Mr. Dunne’s other prior experience includes roles as a Senior Project Accountant for Akridge, where he was responsible for the accounting activities of a portfolio of commercial real estate partnerships and corporations located in the Washington, D.C. metropolitan area and with Deloitte & Touche LLP, where he managed audits for a number of public and private companies, including preparation for initial public offerings and SEC reporting. Mr. Dunne received a Bachelor of Science degree in Business Management, Accounting from the University of Maryland and is a Certified Public Accountant.